Literature DB >> 28663322

Asthma and corticosteroids: time for a more precise approach to treatment.

Eleanor M Dunican1, John V Fahy2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28663322     DOI： 10.1183/13993003.01167-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

Review 1.  Asthma and Corticosteroid Responses in Childhood and Adult Asthma.

Authors:  Amira Ali Ramadan; Jonathan M Gaffin; Elliot Israel; Wanda Phipatanakul
Journal:  Clin Chest Med       Date:  2019-03       Impact factor: 2.878

2.  Reduction in polyamine catabolism leads to spermine-mediated airway epithelial injury and induces asthma features.

Authors:  V Jain; S Raina; A P Gheware; R Singh; R Rehman; V Negi; T Murray Stewart; U Mabalirajan; A K Mishra; R A Casero; A Agrawal; B Ghosh
Journal:  Allergy       Date:  2018-10       Impact factor: 13.146

3.  Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression.

Authors:  Corrado Pelaia; Claudia Crimi; Alida Benfante; Maria Filomena Caiaffa; Cecilia Calabrese; Giovanna Elisiana Carpagnano; Domenico Ciotta; Maria D'Amato; Luigi Macchia; Santi Nolasco; Girolamo Pelaia; Simona Pellegrino; Nicola Scichilone; Giulia Scioscia; Giuseppe Spadaro; Giuseppe Valenti; Alessandro Vatrella; Nunzio Crimi
Journal:  J Asthma Allergy       Date:  2021-02-22

Review 4.  Interleukin-5 in the Pathophysiology of Severe Asthma.

Authors:  Corrado Pelaia; Giovanni Paoletti; Francesca Puggioni; Francesca Racca; Girolamo Pelaia; Giorgio Walter Canonica; Enrico Heffler
Journal:  Front Physiol       Date:  2019-12-17       Impact factor: 4.566

Review 5.  The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions.

Authors:  Carlo Lombardi; Alvise Berti; Marcello Cottini
Journal:  Curr Res Immunol       Date:  2022-03-21

Review 6.  Benralizumab in the treatment of severe asthma: design, development and potential place in therapy.

Authors:  Corrado Pelaia; Alessandro Vatrella; Andrea Bruni; Rosa Terracciano; Girolamo Pelaia
Journal:  Drug Des Devel Ther       Date:  2018-03-21       Impact factor: 4.162

Review 7.  Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.

Authors:  Corrado Pelaia; Cecilia Calabrese; Alessandro Vatrella; Maria Teresa Busceti; Eugenio Garofalo; Nicola Lombardo; Rosa Terracciano; Girolamo Pelaia
Journal:  Biomed Res Int       Date:  2018-05-10       Impact factor: 3.411

8.  Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA2 LEN study.

Authors:  Viiu Blöndal; Andrei Malinovschi; Fredrik Sundbom; Anna James; Roelinde Middelveld; Karl A Franklin; Bo Lundbäck; Christer Janson
Journal:  Clin Exp Allergy       Date:  2020-10-25       Impact factor: 5.018

9.  Clinical features and associated factors with severe asthma in Salvador, Brazil.

Authors:  Alexssandra Maia Alves; Luane Marques de Mello; Aline Silva Lima Matos; Álvaro Augusto Cruz
Journal:  J Bras Pneumol       Date:  2020-03-13       Impact factor: 2.800
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.